WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.31%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$7.27B
AUM Growth
+$462M
(+6.8%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
14.32%
Holding
987
New
245
Increased
155
Reduced
179
Closed
244
Top Buys
| 1 |
TE Connectivity
TEL
|
$140M |
| 2 |
Booking.com
BKNG
|
$123M |
| 3 |
Electronic Arts
EA
|
$85.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
$77M |
| 5 |
Microsoft
MSFT
|
$66.4M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$231M |
| 2 |
Gilead Sciences
GILD
|
$160M |
| 3 |
Amazon
AMZN
|
$77.2M |
| 4 |
Medtronic
MDT
|
$76.3M |
| 5 |
HCA Healthcare
HCA
|
$60M |
Sector Composition
| 1 | Healthcare | 34.27% |
| 2 | Technology | 31.89% |
| 3 | Industrials | 9.9% |
| 4 | Financials | 6.61% |
| 5 | Consumer Discretionary | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Semtech
SMTC
$5.2B
| $10.3M | 0.14% |
360,587
-815,995
| -69% | -$23.4M |
|
202
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.64B
| $10.1M | 0.13% |
+750,005
| New | +$10.1M |
|
|
DMYS
203
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $10.1M | 0.13% |
1,000,000
| – | – |
|
204
Qualcomm
QCOM
$172B
| $9.97M | 0.13% |
90,703
-32,693
| -26% | -$3.59M |
|
205
Ardelyx
ARDX
$1.58B
| $9.91M | 0.13% |
3,475,960
-1,863,105
| -35% | -$5.31M |
|
206
BlackLine
BL
$3.28B
| $9.89M | 0.13% |
147,014
+135,719
| +1,202% | +$9.13M |
|
207
Waste Connections
WCN
$46.6B
| $9.87M | 0.13% |
+74,450
| New | +$9.87M |
|
208
Pultegroup
PHM
$27.2B
| $9.84M | 0.13% |
+216,137
| New | +$9.84M |
|
209
Vulcan Materials
VMC
$38.6B
| $9.84M | 0.13% |
+56,176
| New | +$9.84M |
|
210
Biogen
BIIB
$20.5B
| $9.83M | 0.13% |
35,509
-38,445
| -52% | -$10.6M |
|
211
Applied Materials
AMAT
$126B
| $9.82M | 0.13% |
100,811
-436,418
| -81% | -$42.5M |
|
|
SJR
212
DELISTED
Shaw Communications Inc.
SJR
| $9.7M | 0.13% |
336,816
-274,186
| -45% | -$7.9M |
|
213
Fortune Brands Innovations
FBIN
$7.09B
| $9.7M | 0.13% |
+169,902
| New | +$9.7M |
|
214
UnitedHealth
UNH
$281B
| $9.66M | 0.13% |
18,222
-11,620
| -39% | -$6.16M |
|
215
Jazz Pharmaceuticals
JAZZ
$7.77B
| $9.63M | 0.13% |
60,443
-4,159
| -6% | -$663K |
|
216
Cardinal Health
CAH
$35.7B
| $9.58M | 0.13% |
124,647
-499,050
| -80% | -$38.4M |
|
217
Arcutis Biotherapeutics
ARQT
$1.94B
| $9.54M | 0.13% |
644,899
+94,503
| +17% | +$1.4M |
|
218
Aclaris Therapeutics
ACRS
$224M
| $9.49M | 0.13% |
602,519
-94,488
| -14% | -$1.49M |
|
219
Viridian Therapeutics
VRDN
$1.52B
| $9.47M | 0.13% |
324,139
+28,265
| +10% | +$826K |
|
|
POSH
220
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $9.45M | 0.13% |
+528,710
| New | +$9.45M |
|
221
Keros Therapeutics
KROS
$632M
| $9.45M | 0.13% |
196,699
-145,794
| -43% | -$7M |
|
222
RadNet
RDNT
$5.56B
| $9.4M | 0.13% |
498,941
+266,780
| +115% | +$5.02M |
|
223
ResMed
RMD
$40.1B
| $9.34M | 0.13% |
+44,882
| New | +$9.34M |
|
|
HERA
224
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $9.32M | 0.12% |
921,381
| – | – |
|
|
EMO
225
ClearBridge Energy Midstream Opportunity Fund
EMO
$869M
| $9.15M | 0.12% |
+320,009
| New | +$9.15M |
|